TY  - JOUR
AU  - Rodriguez-Gabella, Tania
AU  - Catalá, Pablo
AU  - Muñoz-García, Antonio J
AU  - Nombela-Franco, Luis
AU  - Del Valle, Raquel
AU  - Gutiérrez, Enrique
AU  - Regueiro, Ander
AU  - Jimenez-Diaz, Victor A
AU  - Ribeiro, Henrique B
AU  - Rivero, Fernando
AU  - Fernandez-Diaz, Jose Antonio
AU  - Pibarot, Philippe
AU  - Alonso-Briales, Juan H
AU  - Tirado-Conte, Gabriela
AU  - Moris, César
AU  - Diez Del Hoyo, Felipe
AU  - Jiménez-Britez, Gustavo
AU  - Zaderenko, Nicolas
AU  - Alfonso, Fernando
AU  - Gómez, Itziar
AU  - Carrasco-Moraleja, Manuel
AU  - Rodés-Cabau, Josep
AU  - San Román Calvar, J Alberto
AU  - Amat-Santos, Ignacio J
PY  - 2019
DO  - 10.1016/j.jacc.2019.05.055
UR  - http://hdl.handle.net/10668/14354
T2  - Journal of the American College of Cardiology
AB  - Several studies have demonstrated the benefits of transcatheter aortic valve replacement (TAVR) in patients with aortic stenosis, but the presence of persistent fibrosis and myocardial hypertrophy has been related to worse prognosis. The aim of this...
LA  - en
KW  - RAS inhibitors
KW  - TAVR
KW  - fibrosis
KW  - hypertrophy
KW  - Aged, 80 and over
KW  - Angiotensin-Converting Enzyme Inhibitors
KW  - Aortic Valve
KW  - Aortic Valve Stenosis
KW  - Echocardiography
KW  - Female
KW  - Follow-Up Studies
KW  - Heart Ventricles
KW  - Humans
KW  - Male
KW  - Postoperative Complications
KW  - Postoperative Period
KW  - Retrospective Studies
KW  - Risk Factors
KW  - Transcatheter Aortic Valve Replacement
KW  - Treatment Outcome
KW  - Ventricular Dysfunction, Left
KW  - Ventricular Function, Left
KW  - Ventricular Remodeling
TI  - Renin-Angiotensin System Inhibition Following Transcatheter Aortic Valve Replacement.
TY  - research article
VL  - 74
ER  -